Celerion Company Culture

Susan Flynn serves as Executive Director, Global Head of Quality Assurance of Celerion. Susan currently resides in the Phoenix, Arizona Area.

Traci Chapek serves as Executive Director, Global Information Technology of Celerion. Traci currently resides in the Lincoln, Nebraska Area.

Ms. Rosal is a senior financial executive with extensive business management experience in North America and Europe. Most recently, she served as Chief Financial Officer and Vice President of Internal Services for Constructive Technologies Group, an Irvine, California-based consulting and engineering firm. Prior to that, Ms. Rosal was Managing Partner and Chief Financial Officer for BioVerum Partners, a healthcare advisory services firm. Ms. Rosal has also held Vice President positions at MDS in finance and administration as well as business systems and processes. Among her accomplishments, Ms. Rosal led a finance team of 70 professionals worldwide in the consolidation of dispersed operations across 20 countries into a harmonized global business. She has developed integrated financial reporting and budgeting tools to improve operations and profitability and implemented pricing structures to achieve desired margins consistent with business targets. She holds a B.A. in Business Economics from University of California, Santa Barbara and is also a Certified Public Accountant (CPA) with membership in the American Institute of CPAs and the California Society of CPAs.

Mr. Bach serves as Vice President of Clinical Research. He is responsible for leading the largest global Phase I and IIa clinical operations networks in the industry, has extensive experience in private and public clinical research environments, and has a thorough understanding of the needs and requirements of clients. Prior to this role, he was recruited into the role of Clinical Site Director for the Phoenix, AZ facility for MDS Pharma Services to rebuild and reposition for growth. Mr. Bach aggressively grew the business, while streamlining operations to deliver high quality service in a timely manner. The successful turnaround of this facility led to the expansion of the clinic from a 120-bed facility to over 300 beds. Mr. Bach led the team for the design and build of the new state-of-the-art clinical research facility, successfully launching it on time and on budget. Mr. Bach also served as Clinical Operations Manager in Lincoln, NE, where he was responsible for operational execution, management and conduct of all clinical trials. Mr. Bach began his career with MDS Harris in 1998, where he held positions of increasing responsibility, enabling him to gain hands-on experience in all aspects of the business.

Dr. Combs serves as the Vice President of Data Management and Biometrics, one of the largest and most experienced groups in the industry. In this role she is responsible for modeling and simulation, protocol development, data programming, biostatistics, pharmacokinetics, and medical writing. Dr. Combs has successfully harmonized global processes from legacy companies and sites to deliver consistency of data and to ensure the highest level of scientific excellence across all client programs. Dr. Combs has over 20 years’ experience in clinical development and has done extensive research in a variety of areas, with publications and presentations on topics focusing in safety, tolerability, pharmacokinetics, and efficacy of new compounds and formulations. Dr. Combs has specialized in early clinical research for the past 17 years, giving her in-depth expertise in the scientific and logistical challenges faced by clients. She is currently focused on the automation of data delivery and innovative study designs, including adaptive trials, to accelerate drug development. Dr. Combs joined MDS Harris in 1997 and held positions of increasing responsibility in biostatistics and pharmacokinetics before leading the Global Clinical Pharmacology Sciences department at MDS Pharma Services. Dr. Combs holds an M.S. and Ph.D. in Biostatistics from the University of Iowa, as well as a B.S. in Mathematics and Statistics from the University of Nebraska at Kearney.

As Vice President of Global Bioanalytical Sciences, Dr. Farmen leads one of the preeminent bioanalytical groups in the industry. In this role he is responsible for the bioanalytical groups in Lincoln, NE and Zurich, Switzerland. These groups offer exceptional expertise in both small and large molecule method development and sample processing in an extremely automated and compliant environment. Dr. Farmen has over 30 years of experience in the CRO and pharmaceutical industries. Prior to joining Celerion, he held executive positions at PharmOptima, a CRO that specializes in ocular research services; Eurofins AvTech Laboratories, which specializes in small and large molecule bioanalytical chemistry as well as QC testing and analysis of finished drug products and pharmaceutical ingredients; and Camargo Pharmaceutical Services, which provides scientific and regulatory oversight during the drug development process. Dr. Farmen also held leadership positions in bioanalytical sciences at MDS Pharma Services, Phoenix International Life Sciences, and Bristol-Myers Squibb. Dr. Farmen earned his doctorate in pharmacology from Indiana University and did post-doctoral research in Biochemistry at the Upstate Medical Center in Syracuse, New York.